tPA inhibitor, tPA:Ag, plasminogen, and α2-antiplasmin after low molecular weight heparin or standard heparin
- 31 January 1987
- journal article
- Published by Elsevier BV in Fibrinolysis
- Vol. 1 (1), 39-43
- https://doi.org/10.1016/0268-9499(87)90031-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A new low molecular weight heparin fragment (PK 10169): In vitro and in vivo studiesThrombosis Research, 1985
- Evidence for a rapid inhibitor to tissue plasminogen activator in plasmaThrombosis Research, 1983
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic DiseaseThrombosis and Haemostasis, 1983
- Influence of heparin;of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysisThrombosis Research, 1982
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- Blood Fibrinolytic Activity in ManCirculation Research, 1970
- Effect of age, sex, and diurnal variation on the human fibrinolytic systemJournal of Clinical Pathology, 1967